Sign In
Buy SMMT
$15.07
+0.210 (+1.41%)
At Close: Jun 03, 2026
Summit Therapeutics to Host Fourth Quarter & Full Year 2023 Financial Results & Operational Progress Call on February 20, 2024
10:29am, Wednesday, 14'th Feb 2024
MIAMI, Fla.--(BUSINESS WIRE)---- $SMMT--Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit,” “we,” or the “Company”) will host an earnings call to announce its fourth quarter and full year 2
Summit Therapeutics: Not For Retail Investors
03:00pm, Tuesday, 26'th Sep 2023
Summit Therapeutics Inc., backed by biotech billionaire Bob Duggan, has transitioned from developing antibiotics to becoming an oncology therapeutics developer. The company purchased the oncology asse
Why Shares of Summit Therapeutics Slumped on Tuesday
01:21pm, Tuesday, 16'th May 2023
Summit's cash position is worrying. The company only has one therapy in clinical trials.
Why Shares of Summit Therapeutics Soared This Week
05:08pm, Friday, 05'th May 2023
The company's current pipeline only includes two drugs. Summit Therapeutics' shares are up more than 93% over the past 12 months.
Strong Small-Cap Insider Buys: Q1 2023
12:15am, Wednesday, 26'th Apr 2023
Strong Small-Cap Insider Buys: Q1 2023.
Summit Therapeutics: Another Billionaire Project That Isn't Going Anywhere
10:49am, Thursday, 13'th Apr 2023
Summit Therapeutics is mostly owned by Bob Duggan, who made billions from selling Pharmacyclics. However, Pharmacyclics had something to sell.
Summit Therapeutics Inc. (SMMT) Q4 2022 Earnings Call Transcript
06:43pm, Friday, 10'th Mar 2023
Summit Therapeutics Inc. (NASDAQ:SMMT ) Q4 2022 Results Conference Call March 9, 2023 9:00 AM ET Company Participants Dave Gancarz - SVP, Corporate Strategy and Stakeholder Relations Dr. Maky Zanganeh
Summit Therapeutics: Ivonescimab Deal Potential Mid-Term Growth Driver
10:00am, Friday, 27'th Jan 2023
Summit Therapeutics rallied hard off 52-week lows in December after its licensing deal for Ivonescimab was announced. Gains have extended into the new year, which is promising for those seeking to ent
5 Best and Worst Performing Small-Cap Stocks in Q4 2022
10:53pm, Thursday, 26'th Jan 2023
The fourth quarter of 2022 was relatively better for the stock markets, with the S&P 500 up over 7% (its only positive quarterly return for the year).
5 Best and Worst Performing Small-Cap Stocks in Dec 2022
10:59pm, Tuesday, 17'th Jan 2023
Small-cap stocks usually suffer more than mid- and large-cap stocks when the market as a whole is struggling, and when the market is rallying, they could offer higher returns as well.
Why Summit Therapeutics Shares Soared This Week
01:25pm, Friday, 30'th Dec 2022
The clinical-stage biopharma stock has been rising all year.
3 Short Squeeze Penny Stocks To Watch Before 2023
11:38am, Wednesday, 28'th Dec 2022
Short squeeze penny stocks to watch. The post 3 Short Squeeze Penny Stocks To Watch Before 2023 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Investing in Penny Stocks? 5 Basic Terms to Know
06:00am, Saturday, 10'th Dec 2022
Five must-know terms for investing in penny stocks The post Investing in Penny Stocks? 5 Basic Terms to Know appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Why Summit Therapeutics Stock Is Skyrocketing This Week
04:45pm, Thursday, 08'th Dec 2022
The company announced an important licensing deal.
Summit Therapeutics (SMMT) Stock Skyrocketed 194.27%: Details
06:24pm, Tuesday, 06'th Dec 2022
The stock price of Summit Therapeutics (SMMT) surged by 194.27% today. This is why.
